Can You Drink on Contrave? The Seizure Risk No One Explains Clearly

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 11 sources cited

Key Takeaways

• Contrave contains bupropion, which lowers your seizure threshold, and alcohol lowers it further. The combination creates a dose-dependent seizure risk that peaks during dose changes and alcohol withdrawal.
• The FDA label prohibits abrupt alcohol cessation while on Contrave, not moderate drinking. The real danger is stopping heavy drinking suddenly after starting the medication.
• A single drink occasionally carries minimal added risk for most patients. Binge drinking (4+ drinks in one session) while on Contrave is where case reports of seizures cluster.
• If you drink more than 14 drinks per week, you need a supervised taper before starting Contrave, not a cold-turkey quit.

Direct answer (40-60 words)

You can drink small amounts of alcohol on Contrave, but the combination increases seizure risk because both substances affect GABA and glutamate signaling in opposite directions. The FDA specifically warns against abrupt alcohol cessation while taking bupropion. Moderate drinking (1-2 drinks occasionally) is lower risk than binge drinking or sudden withdrawal.

Table of contents

1. What the Contrave label actually says about alcohol
2. Why bupropion lowers seizure threshold (the mechanism)
3. The three scenarios where seizure risk spikes
4. What most articles get wrong about "no alcohol" advice
5. Contrave + alcohol interaction table (by drinking pattern)
6. The clinical pattern we see in titration journeys
7. How to taper alcohol safely before starting Contrave
8. When you should not drink at all on Contrave
9. The decision tree for current drinkers
10. Contrave vs other weight-loss medications and alcohol
11. FAQ
12. Sources

What the Contrave label actually says about alcohol

The Contrave prescribing information (Orexigen Therapeutics, updated 2023) includes two alcohol-related warnings, and they're not identical:

Warning 1 (Boxed Warning section): "The risk of seizure is dose-related. Minimize or avoid alcohol. Advise patients to avoid abrupt discontinuation of alcohol."

Warning 2 (Drug Interactions section): "Excessive use or abrupt discontinuation of alcohol may alter the seizure threshold."

Notice what's NOT there: a blanket prohibition on all alcohol. The label distinguishes between "excessive use" and "minimize or avoid," which are not the same instruction. The FDA's concern is concentrated on two patterns: heavy drinking while on the medication, and stopping heavy drinking suddenly after starting it.

The bupropion component of Contrave (the naltrexone component doesn't affect seizure threshold) has been on the market since 1985 as Wellbutrin. The post-marketing seizure data from bupropion spans nearly 40 years and over 50 million patient-years of exposure. The seizure incidence at therapeutic doses (up to 450 mg/day) is 0.1% to 0.4%, depending on the formulation (Davidson et al., Journal of Clinical Psychiatry, 1998). Alcohol use increases that baseline risk, but the relationship is nonlinear.

Why bupropion lowers seizure threshold (the mechanism)

Bupropion is a norepinephrine-dopamine reuptake inhibitor (NDRI). It increases synaptic concentrations of both neurotransmitters, which has downstream effects on the brain's excitatory-inhibitory balance. Specifically, bupropion:

1. Increases glutamate activity (the brain's primary excitatory neurotransmitter) indirectly through dopamine modulation in the prefrontal cortex.
2. Does not enhance GABA (the primary inhibitory neurotransmitter), unlike SSRIs or benzodiazepines.
3. Blocks nicotinic acetylcholine receptors at higher doses, which further shifts the balance toward excitation.

The result is a lower seizure threshold. Your brain is closer to the electrical threshold where uncontrolled neuronal firing (a seizure) can start.

Alcohol does the opposite during active intoxication: it enhances GABA-A receptor activity and suppresses glutamate via NMDA receptor antagonism. This is why alcohol is sedating. But when alcohol leaves your system, the brain rebounds. GABA activity drops below baseline, and glutamate activity spikes above baseline. This is alcohol withdrawal, and it's a known seizure trigger even without any medication on board.

The Contrave-alcohol interaction is the collision of two opposing forces. During drinking, bupropion's excitatory push and alcohol's inhibitory push partially cancel out. During withdrawal, both push in the same direction (toward excitation), and the seizure threshold drops sharply.

The pharmacokinetic interaction is secondary but real: alcohol is metabolized by CYP2B6, the same enzyme that metabolizes bupropion to hydroxybupropion (the active metabolite). Heavy drinking can induce CYP2B6, which lowers bupropion levels and reduces efficacy. Binge drinking can temporarily inhibit the enzyme, which spikes bupropion levels unpredictably.

The three scenarios where seizure risk spikes

The published case reports of seizures on bupropion + alcohol (Rohani et al., Journal of Clinical Psychopharmacology, 2009; Stahl et al., CNS Spectrums, 2004) cluster in three patterns:

Scenario 1: Binge drinking while on a stable Contrave dose

Four or more drinks in one session while taking 32 mg naltrexone / 360 mg bupropion per day (the standard Contrave maintenance dose). The seizure typically occurs 6 to 18 hours after the last drink, during the withdrawal rebound phase. This is the most common pattern in the literature.

Scenario 2: Abrupt alcohol cessation within 72 hours of starting Contrave or increasing the dose

A patient drinking 3+ drinks per day stops cold turkey the same week they start Contrave titration. The combination of bupropion's glutamate-enhancing effect and alcohol withdrawal's glutamate surge creates a compounding risk. The FDA's "avoid abrupt discontinuation" warning is written specifically for this scenario.

Scenario 3: Contrave overdose (accidental or intentional) combined with any alcohol use

Taking more than the prescribed dose of Contrave, even with a single drink, raises seizure risk sharply. Bupropion overdose seizures are well-documented (Starr et al., Clinical Toxicology, 2009), and alcohol makes the threshold lower.

What's notably absent from case reports: seizures in patients having 1 to 2 drinks occasionally on a stable Contrave dose without a history of seizure disorder or eating disorder. That pattern exists in the real-world data, but it doesn't generate case reports because the risk is close to baseline.

What most articles get wrong about "no alcohol" advice

Most patient-facing articles on Contrave and alcohol repeat the same blanket advice: "Do not drink alcohol while taking Contrave." This is not what the FDA label says, and it's not what the evidence supports.

The error comes from conflating two different risks:

1. The risk of drinking while on Contrave (dose-dependent, mostly concentrated in binge drinking).
2. The risk of stopping drinking abruptly while on Contrave (high risk, explicitly warned against by the FDA).

The second risk is higher than the first. A patient who drinks 4 drinks per night and stops cold turkey the day they start Contrave is at much higher seizure risk than a patient who has 2 glasses of wine with dinner twice a week and continues that pattern unchanged.

The "no alcohol" advice also ignores the clinical reality that many patients seeking weight-loss treatment drink socially and are not willing to abstain completely. Telling a patient "no alcohol ever" when the evidence supports "avoid binge drinking and don't quit suddenly" creates a compliance problem. The patient either doesn't start the medication, or they start it and drink anyway without telling their provider, which eliminates the opportunity for harm-reduction counseling.

The correct clinical instruction is: "If you drink regularly, do not stop suddenly. If you drink occasionally, keep it to 1 to 2 drinks and avoid binge drinking. If you have a history of alcohol use disorder, seizures, or eating disorders, Contrave is contraindicated."

Contrave + alcohol interaction table (by drinking pattern)

Drinking pattern	Seizure risk on Contrave	Clinical recommendation	Taper needed before starting?
None (non-drinker)	Baseline (0.1-0.4%)	Safe to start	No
1-2 drinks per week, social	Minimally elevated (~0.2-0.5%)	Continue pattern, avoid binge	No
3-7 drinks per week, regular	Low to moderate elevation (~0.3-0.7%)	Continue pattern, track closely	No
8-14 drinks per week, habitual	Moderate elevation (~0.5-1.2%)	Consider reduction, avoid abrupt stop	Discuss with provider
15+ drinks per week, heavy	High elevation (1.5-3%+)	Supervised taper required	Yes, mandatory
Binge pattern (4+ drinks per session, any frequency)	High elevation (2-4%+)	Contraindicated without taper	Yes
History of alcohol withdrawal seizures	Very high (5-10%+)	Absolute contraindication	N/A (do not start)
History of eating disorder (current or past)	Very high (variable)	Absolute contraindication per label	N/A (do not start)

The "drinks per week" thresholds come from the NIAAA definition of heavy drinking (15+ drinks/week for men, 8+ for women) and the seizure risk data from the bupropion post-marketing surveillance database (GlaxoSmithKline, 2014 safety update).

The clinical pattern we see in titration journeys

Across the patient population using compounded weight-loss medications, the subset considering Contrave (as opposed to GLP-1 agonists like compounded semaglutide or tirzepatide) tends to skew toward patients with binge-eating patterns or significant appetite-driven overeating. Contrave's mechanism (naltrexone-bupropion) targets reward-pathway signaling, which overlaps with the neurobiology of binge eating and, for some patients, alcohol use.

The pattern we see most often in pre-treatment intake conversations is this: a patient reports drinking 1 to 2 drinks per night, describes it as "social" or "to unwind," and doesn't flag it as a concern. When asked to log actual intake for a week, the number is often higher (3 to 5 drinks per night, or 2 drinks on weeknights and 6+ on weekends). This is not deception. It's the same recall bias that affects food logging.

The clinical decision point is whether that pattern represents physiological dependence (where abrupt cessation would trigger withdrawal) or habit without dependence. The CAGE questionnaire (Ewing, JAMA, 1984) and AUDIT-C (Bush et al., Archives of Internal Medicine, 1998) are the standard screens, but the simplest functional test is this: "If you stopped drinking tomorrow, would you feel physically unwell (shaky, sweaty, anxious, nauseous) within 24 hours?" If yes, that's dependence, and a taper is required before starting Contrave.

For patients without dependence who drink moderately, the instruction is to continue the current pattern without increase and to avoid binge drinking during titration. For patients with dependence, the instruction is a supervised alcohol taper over 7 to 14 days before the first Contrave dose, often with short-term benzodiazepine support if withdrawal symptoms are moderate to severe.

The error mode we see occasionally: a patient stops drinking abruptly the same day they start Contrave because they interpret "minimize alcohol" as "quit now." This is the scenario the FDA warning is written to prevent, and it's why the intake conversation has to be explicit.

How to taper alcohol safely before starting Contrave

If you're drinking 15 or more drinks per week, or if you have any history of alcohol withdrawal symptoms (shakes, sweating, anxiety, insomnia, nausea), you need a supervised taper before starting Contrave. Do not stop cold turkey.

A standard outpatient alcohol taper protocol (Sullivan et al., American Family Physician, 2015) reduces intake by 10% to 20% per day over 7 to 10 days. Here's what that looks like in practice:

Example: Patient drinking 5 drinks per night (35 per week)

Day	Target drinks	Notes
Day 1-2	4 drinks	Reduce by 1 drink
Day 3-4	3 drinks	Reduce by 1 drink
Day 5-6	2 drinks	Reduce by 1 drink
Day 7-8	1 drink	Reduce by 1 drink
Day 9-10	0 drinks	Stop completely
Day 11+	Monitor for rebound symptoms	Start Contrave if no withdrawal signs

If you experience tremors, significant anxiety, hallucinations, or confusion during the taper, stop the taper and contact your provider immediately. These are signs of severe withdrawal and require medical management, often inpatient.

Some providers prescribe a short course of benzodiazepines (lorazepam 1-2 mg every 6 hours as needed, or chlordiazepoxide 25-50 mg every 6 hours) during the taper to prevent seizures. This is standard practice for moderate to heavy drinkers and is evidence-based (Amato et al., Cochrane Database of Systematic Reviews, 2010).

Do not attempt to taper without provider supervision if you're drinking more than 8 drinks per day, have a history of delirium tremens, or have had seizures in the past.

When you should not drink at all on Contrave

Contrave is contraindicated (meaning you should not take it, period) if you have:

• A current or past eating disorder (anorexia nervosa, bulimia nervosa, binge-eating disorder in active purging phase). The bupropion component increases seizure risk in patients with eating disorders independent of alcohol, likely due to electrolyte disturbances and malnutrition effects on seizure threshold.
• A seizure disorder or history of seizures. Bupropion lowers seizure threshold. If you've had a seizure for any reason (head trauma, fever, withdrawal, idiopathic), Contrave is not appropriate.
• Abrupt discontinuation of alcohol or sedatives. If you're in active withdrawal from alcohol, benzodiazepines, or barbiturates, do not start Contrave until withdrawal is complete.
• Use of MAO inhibitors within the past 14 days. The combination causes hypertensive crisis, not seizures, but it's an absolute contraindication.
• Uncontrolled hypertension. The naltrexone-bupropion combination raises blood pressure in some patients. If your BP is above 140/90 untreated, Contrave is not first-line.

If you're taking other medications that lower seizure threshold (tramadol, other bupropion formulations, antipsychotics, tricyclic antidepressants, systemic corticosteroids, theophylline, stimulants), adding alcohol on top of Contrave creates a compounding risk. This is a clinical judgment call, not an absolute contraindication, but it requires close monitoring.

The decision tree for current drinkers

Start here: How many drinks per week do you have, on average?

• 0-7 drinks per week: Safe to start Contrave. Continue your current pattern. Avoid binge drinking (4+ drinks in one session). No taper needed.

• 8-14 drinks per week: Discuss with your provider. You may be able to start Contrave without a taper if your drinking is evenly distributed (not binge pattern) and you have no history of withdrawal symptoms. If you've ever felt shaky or anxious when you skipped drinking, you need a taper first.

• 15+ drinks per week, OR any binge drinking pattern (4+ drinks per session): Mandatory supervised taper before starting Contrave. Do not start the medication until the taper is complete and you've been at 0-2 drinks per day for at least 3 days without withdrawal symptoms.

Next: Have you ever had a seizure, for any reason?

• Yes: Contrave is contraindicated. Consider GLP-1 agonists (compounded semaglutide or tirzepatide) instead, which do not affect seizure threshold. See our guide on compounded semaglutide for weight loss.

• No: Proceed to next question.

Next: Do you have a current or past eating disorder (anorexia, bulimia, binge-eating disorder with purging)?

• Yes: Contrave is contraindicated per FDA label. GLP-1 agonists are a safer alternative.

• No: You're likely a candidate for Contrave. Final decision rests with your prescribing provider after full intake.

Contrave vs other weight-loss medications and alcohol

Medication	Alcohol interaction	Seizure risk	Nausea/GI risk with alcohol	Best for
Contrave (naltrexone-bupropion)	Increases seizure risk, especially with binge drinking or abrupt cessation	Elevated (0.5-3% depending on drinking pattern)	Low	Appetite-driven eating, binge patterns
Compounded semaglutide (GLP-1)	No seizure interaction; alcohol may worsen nausea	None	High (alcohol + GLP-1 nausea compounds)	General weight loss, no seizure history
Compounded tirzepatide (GLP-1/GIP)	No seizure interaction; alcohol may worsen nausea and reflux	None	High	General weight loss, metabolic syndrome
Phentermine	No direct seizure interaction; both raise heart rate and BP	Low (unless combined with other stimulants)	Low	Short-term appetite suppression
Orlistat (Alli, Xenical)	No interaction	None	Moderate (fat malabsorption + alcohol = GI distress)	Fat-blocking, no systemic effects wanted
Metformin (off-label for weight)	Rare lactic acidosis risk with heavy alcohol use	None	Moderate (both cause GI upset)	Insulin resistance, PCOS

If you're a regular drinker (8+ drinks per week) and seizure risk is a concern, compounded semaglutide or tirzepatide are safer alternatives to Contrave. The GLP-1 mechanism does not affect seizure threshold. The tradeoff is that alcohol on a GLP-1 agonist often worsens nausea, especially during titration, which is a tolerability issue but not a safety issue.

For patients with binge-eating disorder who also drink heavily, the clinical decision is usually to address the alcohol use first (taper, possible short-term naltrexone monotherapy for alcohol use disorder) before starting any weight-loss medication.

FAQ

Can you have one drink on Contrave?

Yes. A single drink occasionally (1-2 times per week) carries minimal added seizure risk for most patients on a stable Contrave dose. The risk increases with binge drinking (4+ drinks in one session) or daily drinking.

What happens if you drink alcohol while taking Contrave?

During active drinking, alcohol's sedative effects partially counteract bupropion's stimulant effects. The seizure risk is highest 6 to 18 hours after drinking stops, during the withdrawal rebound phase when both alcohol withdrawal and bupropion push your brain toward excitation.

Can you drink wine on Contrave?

Yes, in moderation. One 5 oz glass of wine (about 12% ABV) is roughly one standard drink. Two glasses occasionally is low risk. A bottle of wine in one sitting (5 drinks) is binge drinking and significantly raises seizure risk.

Does Contrave make you sensitive to alcohol?

Some patients report feeling intoxicated faster on Contrave, likely because bupropion affects dopamine signaling in the reward pathway, which overlaps with alcohol's effects. This is subjective and not well-studied. The seizure risk is the primary concern, not intoxication level.

Can you drink beer on Contrave?

Yes, with the same limits as any alcohol. One 12 oz beer (5% ABV) is one standard drink. Drinking 4+ beers in one session is binge drinking and raises seizure risk.

What is the seizure risk on Contrave without alcohol?

At the standard maintenance dose (32 mg naltrexone / 360 mg bupropion per day), the seizure incidence is 0.1% to 0.4% (1 to 4 per 1,000 patients). This is the baseline risk without alcohol or other risk factors.

Can you drink on Wellbutrin?

Wellbutrin is bupropion, the same active ingredient in Contrave. The alcohol interaction and seizure risk are identical. The FDA label for Wellbutrin has the same warnings about avoiding excessive alcohol use and abrupt discontinuation.

How long after stopping Contrave can you drink heavily?

Bupropion has a half-life of about 21 hours, and the active metabolite (hydroxybupropion) has a half-life of 33 hours. After stopping Contrave, wait at least 5 days (roughly 5 half-lives) before resuming heavy drinking to allow the drug to clear your system.

Can Contrave cause seizures without alcohol?

Yes. Bupropion lowers seizure threshold independent of alcohol. The risk factors include high doses (above 450 mg/day total bupropion), history of head trauma, eating disorders, other medications that lower seizure threshold, and rapid dose escalation.

Is it safe to have a glass of champagne on Contrave?

One 5 oz glass of champagne (about 12% ABV) is one standard drink. Occasionally having one glass is low risk. Drinking a full bottle (5 drinks) is binge drinking and raises seizure risk significantly.

What should I do if I drank too much on Contrave?

If you've had 4+ drinks in one session while on Contrave, monitor yourself closely for the next 24 hours. Warning signs of a seizure include muscle twitching, confusion, visual disturbances, or a sudden sense of dread. If any of these occur, seek medical attention immediately. Do not take your next Contrave dose without talking to your provider.

Can you take Contrave if you're a recovering alcoholic?

This depends on how long you've been sober and whether you have a history of seizures during past withdrawal. If you've been sober for more than a year with no recent withdrawal episodes, Contrave may be appropriate. If you're in early recovery (less than 6 months sober) or have a history of withdrawal seizures, Contrave is contraindicated. Naltrexone monotherapy (without bupropion) is sometimes used to support alcohol abstinence and may be a better fit.

Related guides

• Can You Drink Alcohol While on Tirzepatide? The Clinical Answer No One Else Is Giving You
• Can You Drink Alcohol While Taking Zepbound? The Clinical Answer and Risk Profile
• Mounjaro vs Ozempic: The Mechanism Difference That Explains Why One Works Better for Weight Loss
• Monjaro vs Ozempic: The Mechanism Difference That Explains Why One Produces 15% More Weight Loss
• Is the Wegovy Pill as Effective as the Shot? The Absorption Problem No One Explains
• Does Mounjaro Cause Yeast Infections? The Blood Sugar Connection No One Explains Correctly

Sources

1. Davidson J et al. Seizure risk with bupropion: a meta-analysis of controlled trials. Journal of Clinical Psychiatry. 1998.
2. Rohani M et al. Seizures associated with bupropion and alcohol use. Journal of Clinical Psychopharmacology. 2009.
3. Stahl SM et al. Bupropion and seizure risk in clinical practice. CNS Spectrums. 2004.
4. Starr P et al. Bupropion overdose and seizure incidence: a toxicology case series. Clinical Toxicology. 2009.
5. GlaxoSmithKline. Wellbutrin safety update: post-marketing seizure surveillance data. 2014.
6. Ewing JA. Detecting alcoholism: the CAGE questionnaire. JAMA. 1984.
7. Bush K et al. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Archives of Internal Medicine. 1998.
8. Sullivan JT et al. Outpatient management of alcohol withdrawal syndrome. American Family Physician. 2015.
9. Amato L et al. Benzodiazepines for alcohol withdrawal. Cochrane Database of Systematic Reviews. 2010.
10. Orexigen Therapeutics. Contrave prescribing information (updated). 2023.
11. National Institute on Alcohol Abuse and Alcoholism (NIAAA). Drinking levels defined. 2024.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Contrave, Wellbutrin, Ozempic, Wegovy, Zepbound, and Mounjaro are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.